Zuplenz Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Zuplenz General Information

Description

An anti-emetic oral soluble film. The product offers medicines needed for oncology and other therapeutic areas which does not need to be injected or swallowed, offering patients a differentiated alternative to other treatments.

Contact Information

Website
www.zuplenz.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 4640 South West Macadam Avenue
  • Suite 270
  • Portland, OR 97239
  • United States
Primary Industry
Buildings and Property
Other Industries
Medical Supplies
Acquirer
Biodexa Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 4640 South West Macadam Avenue
  • Suite 270
  • Portland, OR 97239
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zuplenz Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zuplenz‘s full profile, request access.

Request a free trial

Zuplenz Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Zuplenz‘s full profile, request access.

Request a free trial

Zuplenz FAQs

  • When was Zuplenz founded?

    Zuplenz was founded in 2015.

  • Where is Zuplenz headquartered?

    Zuplenz is headquartered in Portland, OR.

  • What industry is Zuplenz in?

    Zuplenz’s primary industry is Buildings and Property.

  • Is Zuplenz a private or public company?

    Zuplenz is a Private company.

  • What is the current valuation of Zuplenz?

    The current valuation of Zuplenz is .

  • What is Zuplenz’s current revenue?

    The current revenue for Zuplenz is .

  • Who are Zuplenz’s investors?

    Galena Biopharma has invested in Zuplenz.

  • When was Zuplenz acquired?

    Zuplenz was acquired on 30-Dec-2015.

  • Who acquired Zuplenz?

    Zuplenz was acquired by Biodexa Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process